Printer Friendly
The Free Library
14,550,259 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BIO-REFERENCE REPORTS THIRD QUARTER LOSS.


Bio-Reference Laboratories, Inc (Nasdaq Small Cap-"BRLI BRLI Bio Rad Laboratories Inc "), Elmwood Park Elmwood Park, village (1990 pop. 23,206), Cook co., NE Ill., a suburb of Chicago; inc. 1914. It is chiefly residential. , N.J., has announced a loss of $389,340 for the third quarter of fiscal year 1999, ended July 31, 1999 on revenues of $13,577,696.

This loss is in contrast to a loss in the previous quarter ended April 30, 1999 of $3,634,257 which included a one time write down of goodwill and an additional increase of reserve on accounts receivable accounts receivable n. the amounts of money due or owed to a business or professional by customers or clients. Generally, accounts receivable refers to the total amount due and is considered in calculating the value of a business or the business' problems in paying  relating to the SmithKlein Beecham acquisition and related dialysis testing business unit of $2,924,371. Eliminating the extraordinary charge taken in the second quarter, the company's loss in the third quarter was 35% less than the second quarter's loss. In comparison to the third quarter of fiscal year 1998, in which the company showed a profit of $52,662, the company's revenues were virtually unchanged, despite an increase in patient count of 5%. This is reflected in a decrease in average patient reimbursement of 6% from $45.33 for the three months period ended July 31, 1998, compared to average revenue per patient of $42.79 in the current period. In fact, total cost of services, and general and administrative expenses, (excluding bad debt), were essentially unchanged between the two periods, despite handling the increased number of patients.

Dr. Marc. Grodman, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , stated "Our third quarter is in line with our previous announcements. We have cut our loss from the second quarter and are making the necessary changes to re-orient our laboratory business to either more profitable or more reimbursement-stable segments. The fact that we have controlled costs while increasing our patient count by 5% illustrates that our goal of becoming an efficient producer of laboratory services has started to be realized. In fact, cost of services for the third quarter of 1999 was lower than the second quarter of 1999, even though we had a comparable increase in revenues and patients."

Bio-Reference Laboratories, Inc. is a highly automated computer-driven clinical laboratory serving specialty markets in the New York/Tri- State metropolitan area. The company performs highly sophisticated testing procedures in addition to high-volume routine testing in clinical chemistry, special chemistry, endocrinology, serology Serology

The division of biological science concerned with antigen-antibody reactions in serum. It properly encompasses any of these reactions, but is often used in a limited sense to denote laboratory diagnostic tests, especially for syphilis.
, diagnostic immunology, microbiology, rheumatology rheumatology /rheu·ma·tol·o·gy/ (-tol´ah-je) the branch of medicine dealing with rheumatic disorders, their causes, pathology, diagnosis, treatment, etc.

rheu·ma·tol·o·gy
n.
, parasitology Parasitology

The scientific study of parasites and of parasitism. Parasitism is a subdivision of symbiosis and is defined as an intimate association between an organism (parasite) and another, larger species of organism (host) upon which the parasite is
, cellular immunology, radioimmunoassay, hematology, immunohematology, cytology cytology (sītŏl`əjē), in biology, the study of the structure of all normal and abnormal components of cells and the changes, movements, and transformations of such components. , anatomic pathology and urinalysis.

For more information, call 201/791-2600.
COPYRIGHT 1999 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Biotech Financial Reports
Geographic Code:1USA
Date:Nov 1, 1999
Words:381
Previous Article:PALL REPORTS 27 PERCENT INCREASE IN FOURTH QUARTER EARNINGS.
Next Article:SEPRAGEN REPORTS 56% INCREASE IN 2ND QUARTER REVENUES.
Topics:



Related Articles
Bio-Reference Posts Quarterly Profit On 26% Increase in Revenues; Sixth Consecutive Quarter of Increasing Revenues.
Bio-Reference Laboratories, Inc. Holds Year-end Analysts' Conference Call; Bio-Reference Joined On Call by CEO of Roche Diagnostics.
Bio-Reference Laboratories Announces First Quarter 2002 Earnings Date; Conference Call to be Broadcast On the Internet.
Bio-Reference Laboratories, Inc. Announces Date for Second Quarter Earnings and Conference Call.
Bio-Reference Laboratories, Inc. Announces 168% Increase in Net Income for Second Quarter.
BIO REFERENCE LABS REPORTS RECORD NET INCOME/REVENUE.(Brief Article)(Statistical Data Included)
Bio-Reference Laboratories, Inc. Announces Earnings Date for First Quarter Fiscal Year 2006.
Bio-Reference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2006.
Bio-Reference Laboratories, Inc. Reports Solid Growth on Record Quarterly Revenues; Company Reports 18% Increase in Net Revenues and 93% Increase in...
Bio-Reference Laboratories, Inc. Announces Agreement to Acquire Gene-Based Testing Laboratory, Third Quarter Results and Reaffirms Guidance for Year;...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles